Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside)

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Dec 25, 2024.

Tags:
Previous Thread Next Thread
Loading...
  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    997
    Likes Received:
    55
    Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China rebalancing drive by global innovators likely to continue. Other growth levers are intact. Buy for TP ₹320 (27% upside)

    Download report

    [​IMG]
     
    Vidhi Khanna, Dec 25, 2024
    #1
Previous Thread Next Thread
Loading...
Loading...
Similar Threads
  1. Vidhi Khanna

    Piramal Pharma has an ambitious roadmap to nearly double revenues. TP ₹295 (53% upside)

    Vidhi Khanna, Aug 21, 2025 at 8:35 PM, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    99
    Vidhi Khanna
    Aug 21, 2025 at 8:35 PM
  2. Vidhi Khanna

    Piramal Pharma's long term prospects are intact. Buy for target price of ₹290 (+38%)

    Vidhi Khanna, May 15, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    460
    Vidhi Khanna
    May 15, 2025
  3. Vidhi Khanna

    Piramal Pharma is a conviction pick for Target Price of ₹210 (42% upside)

    Vidhi Khanna, Jul 23, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    879
    Vidhi Khanna
    Jul 23, 2024
  4. Vidhi Khanna

    Buy Piramal Pharma for TP of 200 (42% gain)

    Vidhi Khanna, Nov 15, 2022, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    1,142
    Vidhi Khanna
    Nov 15, 2022
  5. w4wealth

    Markets bullish on Piramal ent@1696, Karur vysya bank@85, vikas ecotech@18, kellton tech@125

    w4wealth, Jan 24, 2017, in forum: Ask A Query About Your Stock Picks And Portfolio
    Replies:
    0
    Views:
    2,038
    w4wealth
    Jan 24, 2017